Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles

Cancer Research

Volumn 64, Issue 12, 2004, Pages 4117-4121

  Furge, Kyle A ^a   Lucas, Kerry A ^a   Takahashi, Masayuki ^a,b   Sugimura, Jun ^a,c   Kort, Eric J ^a   Kanayama, Hiro Omi ^b   Kagawa, Susumu ^b   Hoekstra, Philip ^e   Curry, John ^e   Yang, Ximing J ^d   Teh, Bin T ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d University of Chicago   (United States)

^e SPECTRUM HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CLEAR CELL CARCINOMA; CYTOGENETICS; GENE EXPRESSION; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 3042667856     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0534     Document Type: Article

References (26)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Mostfi FK and Davis CJ. WHO international histological classification of tumors. Berlin: Springer, 1998.
3. Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma: Work-group No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer (Phila) 1997;80:987-9.
4. Moch H, Mihatsch MJ. Genetic progression of renal cell carcinoma. Virchows Arch 2002;4:320-7.
5. Bugert O, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 1996;6:2081-8.
6. Kovacs G. Molecular differential pathology of renal cell tumours. Histopathology 1993;22:1-8.
7. Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003;22:847-52.
8. Takahashi M, Sugimura J, Yang XJ, et al. Molecular sub-classification of kidney cancer and the discovery of new diagnostic markers. Oncogene 2003;22:6810-8.
9. Boer JM, Huber WK, Sultmann H, et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 2001;11:1861-70.
10. Higgins JP, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003;162:925-32.
11. Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001;98:9754-9.
12. Xu XR, Huang J, Xu ZG, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001;98:15089-94.
13. Virtaneva K, Wright FA, Tanner SM, et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 2001;98:1124-9.
14. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002;99:12963-8.
15. Phillips JL, Hayward SW, Wang Y, et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001;61:8143-9.
16. Hughes TR, Roberts CJ, et al. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet 2000;25:333-7.
17. Haddad R, Furge KA, Miller J, et al. Genomic profiling and cDNA microarray analysis of human colon adenocarcinoma and associated peritoneal metastasis reveals consistent cytogenetic and transcriptional aberrations associated with progression of multiple metastases. Appl Genomics Proteomics 2002;1:51-62.
18. Harding MA, Arden KC, Gildea JJ, Perlman EJ, Viars C, Theodorescu D. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 2002;62:6981-9.
19. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene expression data. Genome Biol 2002;3:RESEARCH0075.
20. Sherlock G, Hernandez-Boussard T, Kasarskis A, et al. The Stanford microarray database. Nucleic Acids Res 2001;29:152-5.
21. Clamp M, Andrews D, Barker D, et al. Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res 2003;31:38-42.
22. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
23. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72.
24. Ihaka R, Gentleman RR: a language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
25. Gunawan B, Huber W, Holtrup M, et al. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 2001;61:7731-8.
26. Guo X, Lui WO, Qian CN, et al. Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses., Int J Oncol 2002;21:1197-204.